A PHP Error was encountered

Severity: Warning

Message: fopen(/var/cpanel/php/sessions/ea-php72/ci_session6843e82735fa0bd5f7f4ef86f1c35065438dfdd0): failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 176

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/cpanel/php/sessions/ea-php72)

Filename: Session/Session.php

Line Number: 143

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

Global CRISPR Genome Editing Market Research Report 2024

img

Global CRISPR Genome Editing Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global CRISPR Genome Editing Market Research Report 2024

CRISPR Genome editing is a group of technologies that give scientists the ability to change CRISPR.
According to MRAResearch’s new survey, global CRISPR Genome Editing market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole CRISPR Genome Editing market research.
Key companies engaged in the CRISPR Genome Editing industry include Editas Medicine, CRISPR Therapeutics, Horizon Discovery, Sigma-Aldrich, Genscript, Sangamo Biosciences, Lonza Group, Integrated DNA Technologies and New England Biolabs, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of CRISPR Genome Editing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole CRISPR Genome Editing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global CRISPR Genome Editing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Editas Medicine
CRISPR Therapeutics
Horizon Discovery
Sigma-Aldrich
Genscript
Sangamo Biosciences
Lonza Group
Integrated DNA Technologies
New England Biolabs
Origene Technologies
Transposagen Biopharmaceuticals
Thermo Fisher Scientific
Caribou Biosciences
Precision Biosciences
Cellectis
Intellia Therapeutics
Segment by Type
Genetic Engineering
Gene Library
Human Stem Cells
Others

Segment by Application


Biotechnology Companies
Pharmaceutical Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The CRISPR Genome Editing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRISPR Genome Editing Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Genetic Engineering
1.2.3 Gene Library
1.2.4 Human Stem Cells
1.2.5 Others
1.3 Market by Application
1.3.1 Global CRISPR Genome Editing Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global CRISPR Genome Editing Market Perspective (2018-2033)
2.2 CRISPR Genome Editing Growth Trends by Region
2.2.1 Global CRISPR Genome Editing Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 CRISPR Genome Editing Historic Market Size by Region (2018-2023)
2.2.3 CRISPR Genome Editing Forecasted Market Size by Region (2024-2033)
2.3 CRISPR Genome Editing Market Dynamics
2.3.1 CRISPR Genome Editing Industry Trends
2.3.2 CRISPR Genome Editing Market Drivers
2.3.3 CRISPR Genome Editing Market Challenges
2.3.4 CRISPR Genome Editing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CRISPR Genome Editing Players by Revenue
3.1.1 Global Top CRISPR Genome Editing Players by Revenue (2018-2023)
3.1.2 Global CRISPR Genome Editing Revenue Market Share by Players (2018-2023)
3.2 Global CRISPR Genome Editing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CRISPR Genome Editing Revenue
3.4 Global CRISPR Genome Editing Market Concentration Ratio
3.4.1 Global CRISPR Genome Editing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRISPR Genome Editing Revenue in 2022
3.5 CRISPR Genome Editing Key Players Head office and Area Served
3.6 Key Players CRISPR Genome Editing Product Solution and Service
3.7 Date of Enter into CRISPR Genome Editing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR Genome Editing Breakdown Data by Type
4.1 Global CRISPR Genome Editing Historic Market Size by Type (2018-2023)
4.2 Global CRISPR Genome Editing Forecasted Market Size by Type (2024-2033)
5 CRISPR Genome Editing Breakdown Data by Application
5.1 Global CRISPR Genome Editing Historic Market Size by Application (2018-2023)
5.2 Global CRISPR Genome Editing Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America CRISPR Genome Editing Market Size (2018-2033)
6.2 North America CRISPR Genome Editing Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America CRISPR Genome Editing Market Size by Country (2018-2023)
6.4 North America CRISPR Genome Editing Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CRISPR Genome Editing Market Size (2018-2033)
7.2 Europe CRISPR Genome Editing Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe CRISPR Genome Editing Market Size by Country (2018-2023)
7.4 Europe CRISPR Genome Editing Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CRISPR Genome Editing Market Size (2018-2033)
8.2 Asia-Pacific CRISPR Genome Editing Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific CRISPR Genome Editing Market Size by Region (2018-2023)
8.4 Asia-Pacific CRISPR Genome Editing Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CRISPR Genome Editing Market Size (2018-2033)
9.2 Latin America CRISPR Genome Editing Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America CRISPR Genome Editing Market Size by Country (2018-2023)
9.4 Latin America CRISPR Genome Editing Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CRISPR Genome Editing Market Size (2018-2033)
10.2 Middle East & Africa CRISPR Genome Editing Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa CRISPR Genome Editing Market Size by Country (2018-2023)
10.4 Middle East & Africa CRISPR Genome Editing Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Editas Medicine
11.1.1 Editas Medicine Company Detail
11.1.2 Editas Medicine Business Overview
11.1.3 Editas Medicine CRISPR Genome Editing Introduction
11.1.4 Editas Medicine Revenue in CRISPR Genome Editing Business (2018-2023)
11.1.5 Editas Medicine Recent Development
11.2 CRISPR Therapeutics
11.2.1 CRISPR Therapeutics Company Detail
11.2.2 CRISPR Therapeutics Business Overview
11.2.3 CRISPR Therapeutics CRISPR Genome Editing Introduction
11.2.4 CRISPR Therapeutics Revenue in CRISPR Genome Editing Business (2018-2023)
11.2.5 CRISPR Therapeutics Recent Development
11.3 Horizon Discovery
11.3.1 Horizon Discovery Company Detail
11.3.2 Horizon Discovery Business Overview
11.3.3 Horizon Discovery CRISPR Genome Editing Introduction
11.3.4 Horizon Discovery Revenue in CRISPR Genome Editing Business (2018-2023)
11.3.5 Horizon Discovery Recent Development
11.4 Sigma-Aldrich
11.4.1 Sigma-Aldrich Company Detail
11.4.2 Sigma-Aldrich Business Overview
11.4.3 Sigma-Aldrich CRISPR Genome Editing Introduction
11.4.4 Sigma-Aldrich Revenue in CRISPR Genome Editing Business (2018-2023)
11.4.5 Sigma-Aldrich Recent Development
11.5 Genscript
11.5.1 Genscript Company Detail
11.5.2 Genscript Business Overview
11.5.3 Genscript CRISPR Genome Editing Introduction
11.5.4 Genscript Revenue in CRISPR Genome Editing Business (2018-2023)
11.5.5 Genscript Recent Development
11.6 Sangamo Biosciences
11.6.1 Sangamo Biosciences Company Detail
11.6.2 Sangamo Biosciences Business Overview
11.6.3 Sangamo Biosciences CRISPR Genome Editing Introduction
11.6.4 Sangamo Biosciences Revenue in CRISPR Genome Editing Business (2018-2023)
11.6.5 Sangamo Biosciences Recent Development
11.7 Lonza Group
11.7.1 Lonza Group Company Detail
11.7.2 Lonza Group Business Overview
11.7.3 Lonza Group CRISPR Genome Editing Introduction
11.7.4 Lonza Group Revenue in CRISPR Genome Editing Business (2018-2023)
11.7.5 Lonza Group Recent Development
11.8 Integrated DNA Technologies
11.8.1 Integrated DNA Technologies Company Detail
11.8.2 Integrated DNA Technologies Business Overview
11.8.3 Integrated DNA Technologies CRISPR Genome Editing Introduction
11.8.4 Integrated DNA Technologies Revenue in CRISPR Genome Editing Business (2018-2023)
11.8.5 Integrated DNA Technologies Recent Development
11.9 New England Biolabs
11.9.1 New England Biolabs Company Detail
11.9.2 New England Biolabs Business Overview
11.9.3 New England Biolabs CRISPR Genome Editing Introduction
11.9.4 New England Biolabs Revenue in CRISPR Genome Editing Business (2018-2023)
11.9.5 New England Biolabs Recent Development
11.10 Origene Technologies
11.10.1 Origene Technologies Company Detail
11.10.2 Origene Technologies Business Overview
11.10.3 Origene Technologies CRISPR Genome Editing Introduction
11.10.4 Origene Technologies Revenue in CRISPR Genome Editing Business (2018-2023)
11.10.5 Origene Technologies Recent Development
11.11 Transposagen Biopharmaceuticals
11.11.1 Transposagen Biopharmaceuticals Company Detail
11.11.2 Transposagen Biopharmaceuticals Business Overview
11.11.3 Transposagen Biopharmaceuticals CRISPR Genome Editing Introduction
11.11.4 Transposagen Biopharmaceuticals Revenue in CRISPR Genome Editing Business (2018-2023)
11.11.5 Transposagen Biopharmaceuticals Recent Development
11.12 Thermo Fisher Scientific
11.12.1 Thermo Fisher Scientific Company Detail
11.12.2 Thermo Fisher Scientific Business Overview
11.12.3 Thermo Fisher Scientific CRISPR Genome Editing Introduction
11.12.4 Thermo Fisher Scientific Revenue in CRISPR Genome Editing Business (2018-2023)
11.12.5 Thermo Fisher Scientific Recent Development
11.13 Caribou Biosciences
11.13.1 Caribou Biosciences Company Detail
11.13.2 Caribou Biosciences Business Overview
11.13.3 Caribou Biosciences CRISPR Genome Editing Introduction
11.13.4 Caribou Biosciences Revenue in CRISPR Genome Editing Business (2018-2023)
11.13.5 Caribou Biosciences Recent Development
11.14 Precision Biosciences
11.14.1 Precision Biosciences Company Detail
11.14.2 Precision Biosciences Business Overview
11.14.3 Precision Biosciences CRISPR Genome Editing Introduction
11.14.4 Precision Biosciences Revenue in CRISPR Genome Editing Business (2018-2023)
11.14.5 Precision Biosciences Recent Development
11.15 Cellectis
11.15.1 Cellectis Company Detail
11.15.2 Cellectis Business Overview
11.15.3 Cellectis CRISPR Genome Editing Introduction
11.15.4 Cellectis Revenue in CRISPR Genome Editing Business (2018-2023)
11.15.5 Cellectis Recent Development
11.16 Intellia Therapeutics
11.16.1 Intellia Therapeutics Company Detail
11.16.2 Intellia Therapeutics Business Overview
11.16.3 Intellia Therapeutics CRISPR Genome Editing Introduction
11.16.4 Intellia Therapeutics Revenue in CRISPR Genome Editing Business (2018-2023)
11.16.5 Intellia Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global CRISPR Genome Editing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Genetic Engineering
Table 3. Key Players of Gene Library
Table 4. Key Players of Human Stem Cells
Table 5. Key Players of Others
Table 6. Global CRISPR Genome Editing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global CRISPR Genome Editing Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global CRISPR Genome Editing Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global CRISPR Genome Editing Market Share by Region (2018-2023)
Table 10. Global CRISPR Genome Editing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global CRISPR Genome Editing Market Share by Region (2024-2033)
Table 12. CRISPR Genome Editing Market Trends
Table 13. CRISPR Genome Editing Market Drivers
Table 14. CRISPR Genome Editing Market Challenges
Table 15. CRISPR Genome Editing Market Restraints
Table 16. Global CRISPR Genome Editing Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global CRISPR Genome Editing Market Share by Players (2018-2023)
Table 18. Global Top CRISPR Genome Editing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR Genome Editing as of 2022)
Table 19. Ranking of Global Top CRISPR Genome Editing Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by CRISPR Genome Editing Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players CRISPR Genome Editing Product Solution and Service
Table 23. Date of Enter into CRISPR Genome Editing Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global CRISPR Genome Editing Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global CRISPR Genome Editing Revenue Market Share by Type (2018-2023)
Table 27. Global CRISPR Genome Editing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global CRISPR Genome Editing Revenue Market Share by Type (2024-2033)
Table 29. Global CRISPR Genome Editing Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global CRISPR Genome Editing Revenue Market Share by Application (2018-2023)
Table 31. Global CRISPR Genome Editing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global CRISPR Genome Editing Revenue Market Share by Application (2024-2033)
Table 33. North America CRISPR Genome Editing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America CRISPR Genome Editing Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America CRISPR Genome Editing Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe CRISPR Genome Editing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe CRISPR Genome Editing Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe CRISPR Genome Editing Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific CRISPR Genome Editing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific CRISPR Genome Editing Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific CRISPR Genome Editing Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America CRISPR Genome Editing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America CRISPR Genome Editing Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America CRISPR Genome Editing Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa CRISPR Genome Editing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa CRISPR Genome Editing Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa CRISPR Genome Editing Market Size by Country (2024-2033) & (US$ Million)
Table 48. Editas Medicine Company Detail
Table 49. Editas Medicine Business Overview
Table 50. Editas Medicine CRISPR Genome Editing Product
Table 51. Editas Medicine Revenue in CRISPR Genome Editing Business (2018-2023) & (US$ Million)
Table 52. Editas Medicine Recent Development
Table 53. CRISPR Therapeutics Company Detail
Table 54. CRISPR Therapeutics Business Overview
Table 55. CRISPR Therapeutics CRISPR Genome Editing Product
Table 56. CRISPR Therapeutics Revenue in CRISPR Genome Editing Business (2018-2023) & (US$ Million)
Table 57. CRISPR Therapeutics Recent Development
Table 58. Horizon Discovery Company Detail
Table 59. Horizon Discovery Business Overview
Table 60. Horizon Discovery CRISPR Genome Editing Product
Table 61. Horizon Discovery Revenue in CRISPR Genome Editing Business (2018-2023) & (US$ Million)
Table 62. Horizon Discovery Recent Development
Table 63. Sigma-Aldrich Company Detail
Table 64. Sigma-Aldrich Business Overview
Table 65. Sigma-Aldrich CRISPR Genome Editing Product
Table 66. Sigma-Aldrich Revenue in CRISPR Genome Editing Business (2018-2023) & (US$ Million)
Table 67. Sigma-Aldrich Recent Development
Table 68. Genscript Company Detail
Table 69. Genscript Business Overview
Table 70. Genscript CRISPR Genome Editing Product
Table 71. Genscript Revenue in CRISPR Genome Editing Business (2018-2023) & (US$ Million)
Table 72. Genscript Recent Development
Table 73. Sangamo Biosciences Company Detail
Table 74. Sangamo Biosciences Business Overview
Table 75. Sangamo Biosciences CRISPR Genome Editing Product
Table 76. Sangamo Biosciences Revenue in CRISPR Genome Editing Business (2018-2023) & (US$ Million)
Table 77. Sangamo Biosciences Recent Development
Table 78. Lonza Group Company Detail
Table 79. Lonza Group Business Overview
Table 80. Lonza Group CRISPR Genome Editing Product
Table 81. Lonza Group Revenue in CRISPR Genome Editing Business (2018-2023) & (US$ Million)
Table 82. Lonza Group Recent Development
Table 83. Integrated DNA Technologies Company Detail
Table 84. Integrated DNA Technologies Business Overview
Table 85. Integrated DNA Technologies CRISPR Genome Editing Product
Table 86. Integrated DNA Technologies Revenue in CRISPR Genome Editing Business (2018-2023) & (US$ Million)
Table 87. Integrated DNA Technologies Recent Development
Table 88. New England Biolabs Company Detail
Table 89. New England Biolabs Business Overview
Table 90. New England Biolabs CRISPR Genome Editing Product
Table 91. New England Biolabs Revenue in CRISPR Genome Editing Business (2018-2023) & (US$ Million)
Table 92. New England Biolabs Recent Development
Table 93. Origene Technologies Company Detail
Table 94. Origene Technologies Business Overview
Table 95. Origene Technologies CRISPR Genome Editing Product
Table 96. Origene Technologies Revenue in CRISPR Genome Editing Business (2018-2023) & (US$ Million)
Table 97. Origene Technologies Recent Development
Table 98. Transposagen Biopharmaceuticals Company Detail
Table 99. Transposagen Biopharmaceuticals Business Overview
Table 100. Transposagen Biopharmaceuticals CRISPR Genome Editing Product
Table 101. Transposagen Biopharmaceuticals Revenue in CRISPR Genome Editing Business (2018-2023) & (US$ Million)
Table 102. Transposagen Biopharmaceuticals Recent Development
Table 103. Thermo Fisher Scientific Company Detail
Table 104. Thermo Fisher Scientific Business Overview
Table 105. Thermo Fisher Scientific CRISPR Genome Editing Product
Table 106. Thermo Fisher Scientific Revenue in CRISPR Genome Editing Business (2018-2023) & (US$ Million)
Table 107. Thermo Fisher Scientific Recent Development
Table 108. Caribou Biosciences Company Detail
Table 109. Caribou Biosciences Business Overview
Table 110. Caribou Biosciences CRISPR Genome Editing Product
Table 111. Caribou Biosciences Revenue in CRISPR Genome Editing Business (2018-2023) & (US$ Million)
Table 112. Caribou Biosciences Recent Development
Table 113. Precision Biosciences Company Detail
Table 114. Precision Biosciences Business Overview
Table 115. Precision Biosciences CRISPR Genome Editing Product
Table 116. Precision Biosciences Revenue in CRISPR Genome Editing Business (2018-2023) & (US$ Million)
Table 117. Precision Biosciences Recent Development
Table 118. Cellectis Company Detail
Table 119. Cellectis Business Overview
Table 120. Cellectis CRISPR Genome Editing Product
Table 121. Cellectis Revenue in CRISPR Genome Editing Business (2018-2023) & (US$ Million)
Table 122. Cellectis Recent Development
Table 123. Intellia Therapeutics Company Detail
Table 124. Intellia Therapeutics Business Overview
Table 125. Intellia Therapeutics CRISPR Genome Editing Product
Table 126. Intellia Therapeutics Revenue in CRISPR Genome Editing Business (2018-2023) & (US$ Million)
Table 127. Intellia Therapeutics Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CRISPR Genome Editing Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global CRISPR Genome Editing Market Share by Type: 2022 VS 2033
Figure 3. Genetic Engineering Features
Figure 4. Gene Library Features
Figure 5. Human Stem Cells Features
Figure 6. Others Features
Figure 7. Global CRISPR Genome Editing Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global CRISPR Genome Editing Market Share by Application: 2022 VS 2033
Figure 9. Biotechnology Companies Case Studies
Figure 10. Pharmaceutical Companies Case Studies
Figure 11. Others Case Studies
Figure 12. CRISPR Genome Editing Report Years Considered
Figure 13. Global CRISPR Genome Editing Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global CRISPR Genome Editing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global CRISPR Genome Editing Market Share by Region: 2022 VS 2033
Figure 16. Global CRISPR Genome Editing Market Share by Players in 2022
Figure 17. Global Top CRISPR Genome Editing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR Genome Editing as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by CRISPR Genome Editing Revenue in 2022
Figure 19. North America CRISPR Genome Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America CRISPR Genome Editing Market Share by Country (2018-2033)
Figure 21. United States CRISPR Genome Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada CRISPR Genome Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe CRISPR Genome Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe CRISPR Genome Editing Market Share by Country (2018-2033)
Figure 25. Germany CRISPR Genome Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France CRISPR Genome Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. CRISPR Genome Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy CRISPR Genome Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia CRISPR Genome Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries CRISPR Genome Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific CRISPR Genome Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific CRISPR Genome Editing Market Share by Region (2018-2033)
Figure 33. China CRISPR Genome Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan CRISPR Genome Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea CRISPR Genome Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia CRISPR Genome Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India CRISPR Genome Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia CRISPR Genome Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America CRISPR Genome Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America CRISPR Genome Editing Market Share by Country (2018-2033)
Figure 41. Mexico CRISPR Genome Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil CRISPR Genome Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa CRISPR Genome Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa CRISPR Genome Editing Market Share by Country (2018-2033)
Figure 45. Turkey CRISPR Genome Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia CRISPR Genome Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Editas Medicine Revenue Growth Rate in CRISPR Genome Editing Business (2018-2023)
Figure 48. CRISPR Therapeutics Revenue Growth Rate in CRISPR Genome Editing Business (2018-2023)
Figure 49. Horizon Discovery Revenue Growth Rate in CRISPR Genome Editing Business (2018-2023)
Figure 50. Sigma-Aldrich Revenue Growth Rate in CRISPR Genome Editing Business (2018-2023)
Figure 51. Genscript Revenue Growth Rate in CRISPR Genome Editing Business (2018-2023)
Figure 52. Sangamo Biosciences Revenue Growth Rate in CRISPR Genome Editing Business (2018-2023)
Figure 53. Lonza Group Revenue Growth Rate in CRISPR Genome Editing Business (2018-2023)
Figure 54. Integrated DNA Technologies Revenue Growth Rate in CRISPR Genome Editing Business (2018-2023)
Figure 55. New England Biolabs Revenue Growth Rate in CRISPR Genome Editing Business (2018-2023)
Figure 56. Origene Technologies Revenue Growth Rate in CRISPR Genome Editing Business (2018-2023)
Figure 57. Transposagen Biopharmaceuticals Revenue Growth Rate in CRISPR Genome Editing Business (2018-2023)
Figure 58. Thermo Fisher Scientific Revenue Growth Rate in CRISPR Genome Editing Business (2018-2023)
Figure 59. Caribou Biosciences Revenue Growth Rate in CRISPR Genome Editing Business (2018-2023)
Figure 60. Precision Biosciences Revenue Growth Rate in CRISPR Genome Editing Business (2018-2023)
Figure 61. Cellectis Revenue Growth Rate in CRISPR Genome Editing Business (2018-2023)
Figure 62. Intellia Therapeutics Revenue Growth Rate in CRISPR Genome Editing Business (2018-2023)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed